1 / 11

Ankylosing Spondylitis Market

Ankylosing Spondylitis (AS), also known as Bechterew disease is the rare type of arthritis causing stiffness and intense pain in the individualu2019s spine, starting from lower back sacral bones. AS could also spread to the neck region and damage to other adjoining joints. Ankylosis simply means bone fusion and hard connective tissue and spondylitis means inflammation in the spine and lower part of the vertebrae.

Ronald15
Download Presentation

Ankylosing Spondylitis Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ankylosing Spondylitis Market Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5%

  2. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% “As per Polaris Market Research report, Ankylosing Spondylitis Market is attending major innovations & transformations and is projected to reach $8.45 Billion By 2028 | CAGR: 8.5% during the conjecture period 2021 to 2028.” The global Ankylosing Spondylitis Market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Ankylosing Spondylitis Market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2028. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. ➢Ankylosing Spondylitis Market Report Scope: The global Ankylosing Spondylitis Market is segmented ByDrug, By Treatment Type, By Region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Ankylosing Spondylitis Market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Ankylosing Spondylitis Market growth during the forecast period from 2021-2028. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. - 2 -

  3. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% By Drug By Treatment Type By Region •Cosentyx •Painkillers and non-steroidal anti- •North America (U.S., Canada) •Humira •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) inflammatory drugs (NSAIDs) •Disease-modifying anti-rheumatic •Simponi •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) drugs (DMARDs) •Remicade •Latin America (Brazil, Mexico, Argentina) •Biological therapies •Enbrel •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) •Steroids •Cimzia •Physical therapies •Others •Surgery ➢COVID-19 Impact Analysis for Ankylosing Spondylitis Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Ankylosing Spondylitis Market as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Ankylosing Spondylitis Market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities ➢Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. ➢Browse Detailed Research Report on Ankylosing Spondylitis Market Analysis: https://www.polarismarketresearch.com/industry-analysis/ankylosing-spondylitis-market ➢Competitive Landscape The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a - 3 -

  4. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Ankylosing Spondylitis Market include AbbVie, Inc., Pfizer, Inc., Novartis AG, Amgen, Inc., Johnson & Johnson Services, Inc., Eli Lilly and Company, UCB, Inc., and Merck & Co., Inc. https://www.polarismarketresearch.com/industry-analysis/ankylosing-spondylitis- Request for sample: market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Ankylosing Spondylitis Market Insights 4.1.Ankylosing Spondylitis – Industry snapshot 4.2.Ankylosing Spondylitis Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. Strong drug pipeline 4.2.1.2. Patient awareness regarding its ill effects 4.2.2.Restraints and Challenges 4.2.2.1. High cost of available treatment options 4.3.Porter’s Five Forces Analysis - 4 -

  5. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Ankylosing Spondylitis Market Industry trends 5.Ankylosing Spondylitis Market Assessment by Drug 5.1.Key Findings 5.2.Introduction 5.2.1.Global Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 5.3.Cosentyx 5.3.1.Global Ankylosing Spondylitis Market, by Cosentyx, by Region, 2016 – 2028 (USD Million) 5.4.Humira 5.4.1.Global Ankylosing Spondylitis Market, by Humira, by Region, 2016 – 2028 (USD Million) 5.5.Simponi 5.5.1.Global Ankylosing Spondylitis Market, by Simponi, by Region, 2016 – 2028 (USD Million) 5.6.Remicade 5.6.1.Global Ankylosing Spondylitis Market, by Remicade, by Region, 2016 – 2028 (USD Million) 5.7.Enbrel 5.7.1.Global Ankylosing Spondylitis Market, by Enbrel, by Region, 2016 – 2028 (USD Million) 5.8.Cimzia 5.8.1.Global Ankylosing Spondylitis Market, by Cimzia, by Region, 2016 – 2028 (USD Million) 5.9.Others 5.9.1.Global Ankylosing Spondylitis Market, by Others, by Region, 2016 – 2028 (USD Million) 6.Global Ankylosing Spondylitis Market, by Treatment Type 6.1.Key Findings 6.2.Introduction 6.2.1.Global Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 6.3.Painkillers and non-steroidal anti-inflammatory drugs (NSAIDs) - 5 -

  6. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% 6.3.1.Global Ankylosing Spondylitis Market, by Painkillers and non-steroidal anti- inflammatory drugs (NSAIDs), By Region, 2016 – 2028 (USD Million) 6.4.Disease-modifying anti-rheumatic drugs (DMARDs) 6.4.1.Global Ankylosing Spondylitis Market, by Disease-modifying anti-rheumatic drugs (DMARDs), by Region, 2016 – 2028 (USD Million) 6.5.Biological therapies 6.5.1.Global Ankylosing Spondylitis Market, by Biological therapies, by Region, 2016 – 2028 (USD Million) 6.6.Steroids 6.6.1.Global Ankylosing Spondylitis Market, by Steroids, by Region, 2016 – 2028 (USD Million) 6.7.Physical therapies 6.7.1.Global Ankylosing Spondylitis Market, by Physical therapies, by Region, 2016 – 2028 (USD Million) 6.8.Surgery 6.8.1.Global Ankylosing Spondylitis Market, by Surgery, by Region, 2016 – 2028 (USD Million) 7.Ankylosing Spondylitis Market Assessment by Geography 7.1.Key findings 7.2.Introduction 7.2.1.Ankylosing Spondylitis Market Assessment, By Geography, 2016 – 2028 (USD Million) 7.3.Ankylosing Spondylitis Market – North America 7.3.1.North America: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.3.2.North America: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.3.3.Ankylosing Spondylitis Market – U.S. 7.3.3.1. U.S.: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.3.3.2. U.S.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.3.4.Ankylosing Spondylitis Market – Canada 7.3.4.1. Canada: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.3.4.2. Canada.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.Ankylosing Spondylitis Market – Europe 7.4.1.Europe: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) - 6 -

  7. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% 7.4.2.Europe: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.3.Ankylosing Spondylitis Market – UK 7.4.3.1. UK: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.3.2. UK: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.4.Ankylosing Spondylitis Market – France 7.4.4.1. France: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.4.2. France: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.5.Ankylosing Spondylitis Market – Germany 7.4.5.1. Germany: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.5.2. Germany: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.6.Ankylosing Spondylitis Market – Italy 7.4.6.1. Italy: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.6.2. Italy: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.7.Ankylosing Spondylitis Market – Spain 7.4.7.1. Spain: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.7.2. Spain: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.8.Ankylosing Spondylitis Market – Netherlands 7.4.8.1. Netherlands: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.8.2. Netherlands: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.9.Ankylosing Spondylitis Market – Austria 7.4.9.1. Austria: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.9.2. Austria: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.Ankylosing Spondylitis Market – Asia-Pacific 7.5.1.Asia Pacific: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.2.Asia Pacific: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.3.Ankylosing Spondylitis Market – China 7.5.3.1. China: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) - 7 -

  8. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% 7.5.3.2. China: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.4.Ankylosing Spondylitis Market – India 7.5.4.1. India: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.4.2. India.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.5.Ankylosing Spondylitis Market – Malaysia 7.5.5.1. Malaysia: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.5.2. Malaysia: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.6.Ankylosing Spondylitis Market – Japan 7.5.6.1. Japan: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.6.2. Japan: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.7.Ankylosing Spondylitis Market – Indonesia 7.5.7.1. Indonesia: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.7.2. Indonesia: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.8.Ankylosing Spondylitis Market – South Korea 7.5.8.1. South Korea: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.8.2. South Korea.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.Ankylosing Spondylitis Market – Middle East & Africa 7.6.1.Middle East & Africa: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.6.2.Middle East & Africa.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.3.Ankylosing Spondylitis Market – Saudi Arabia 7.6.3.1. Saudi Arabia: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.6.3.2. Saudi Arabia.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.4.Ankylosing Spondylitis Market – UAE 7.6.4.1. UAE: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.6.4.2. UAE: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.5.Ankylosing Spondylitis Market – Israel 7.6.5.1. Israel: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) - 8 -

  9. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% 7.6.5.2. Israel: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.6.Ankylosing Spondylitis Market – South Africa 7.6.6.1. South Africa: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.6.6.2. South Africa: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.7.Ankylosing Spondylitis Market – Latin America 7.7.1.Latin America: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.7.2.Latin America: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.7.3.Ankylosing Spondylitis Market – Mexico 7.7.3.1. Mexico: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.7.3.2. Mexico.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.7.4.Ankylosing Spondylitis Market – Brazil 7.7.4.1. Brazil: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.7.4.2. Brazil.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.7.5.Ankylosing Spondylitis Market – Argentina 7.7.5.1. Argentina: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.7.5.2. Argentina.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 8.Competitive Landscape 8.1.Expansion and Acquisition Analysis 8.1.1.Expansion 8.2.Partnerships/Collaborations/Agreements/Exhibitions 9.Company Profiles 9.1.AbbVie, Inc. 9.1.1.Company Overview 9.1.2.Financial Performance 9.1.3.Product Benchmarking 9.1.4.Recent Development 9.2.Amgen, Inc. 9.2.1.Company Overview 9.2.2.Financial Performance 9.2.3.Product Benchmarking - 9 -

  10. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% 9.2.4.Recent Development 9.3.Pfizer, Inc. 9.3.1.Company Overview 9.3.2.Financial Performance 9.3.3.Product Benchmarking 9.3.4.Recent Development 9.4.Novartis AG 9.4.1.Company Overview 9.4.2.Financial Performance 9.4.3.Product Benchmarking 9.4.4.Recent Development 9.5.Eli Lilly and Company 9.5.1.Company Overview 9.5.2.Financial Performance 9.5.3.Product Benchmarking 9.5.4.Recent Development 9.6.UCB, Inc. 9.6.1.Company Overview 9.6.2.Financial Performance 9.6.3.Product Benchmarking 9.6.4.Recent Development 9.7.Johnson & Johnson Services, Inc. 9.7.1.Company Overview 9.7.2.Financial Performance 9.7.3.Product Benchmarking 9.7.4.Recent Development 9.8.Merck & Co., Inc. 9.8.1.Company Overview 9.8.2.Financial Performance 9.8.3.Product Benchmarking 9.8.4.Recent Development 9.9.Boehringer Ingelheim International GmbH 9.9.1.Company Overview 9.9.2.Financial Performance 9.9.3.Product Benchmarking 9.9.4.Recent Development ➢Access Press Release on Ankylosing Spondylitis Market: https://www.polarismarketresearch.com/press-releases/ankylosing-spondylitis-market ➢About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the - 10 -

  11. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5% industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 11 -

More Related